Curcumin Gel (Vascarta)

姜黄素凝胶 (Vascarta)

Report date: 2026/05/07 20:00:36
NME

Base Information

Drug NameCurcumin Gel (Vascarta)
Drug Alias NameVasceptorVAS-101
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionDNA (cytosine-5)-methyltransferase 1 inhibitors
TargetsDNA (cytosine-5)-methyltransferase 1
Therapy Area/IndicationsAnemia, Sickle CellOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlbert Einstein College Of Medicine Inc
China Registration ClassN/A

Develop Information

Active CompaniesVascarta IncNational Heart, Lung, And Blood Institute (Nhlbi)
Inactive CompaniesN/A
Active IndicationsAnemia, Sickle CellOsteoarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A